Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2023	Mar. 31, 2023		Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 63,866,000			$ 77,500,000
Restricted cash	488,000			480,000
Short-term investments	630,000			587,000
Trade receivables, net	73,653,000			86,783,000
Deferred cost	354,000			319,000
Prepaid expenses	3,451,000			3,989,000
Other current assets	4,748,000			3,387,000
Total current assets	147,190,000			173,045,000
Property and equipment, net	23,535,000			23,826,000
Operating right-of-use assets	2,599,000			2,931,000
Intangible assets, net	52,678,000			57,400,000
Goodwill	111,905,000			111,526,000
Other long-term assets	2,219,000			1,445,000
Total Assets	340,126,000			370,173,000
Current liabilities:
Accounts payable	73,038,000			82,258,000
Lines of credit	3,468,000			3,955,000
Current portion of notes payable				405,000
Current portion of bank and other borrowings	9,389,000			11,419,000
Deferred revenue	2,443,000			3,528,000
Payroll and payroll related accrued liabilities	6,855,000			5,993,000
Other current liabilities	10,644,000			9,431,000
Total current liabilities	105,837,000			116,989,000
Long-term portion of bank and other borrowings	9,494,000			13,459,000
Long-term portion of notes payable	192,844,000			191,777,000
Long-term portion of employee benefit obligation	2,380,000			2,373,000
Other long-term liabilities	3,193,000			3,362,000
Total Liabilities	313,748,000			327,960,000
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 14,125,366 shares issued and 13,325,920 shares outstanding as of June 30, 2023 and 13,858,440 shares issued and 13,058,994 shares outstanding as of December 31, 2022	1,000			1,000
Additional paid-in capital	282,459,000			278,473,000
Treasury stock, at cost; 799,446 shares as of June 30, 2023 and December 31, 2022	(30,431,000)			(30,431,000)
Accumulated other comprehensive loss	(4,710,000)			(5,212,000)
Accumulated deficit	(220,941,000)			(200,618,000)
Total stockholders’ equity	26,378,000	$ 33,620,000	[1]	42,213,000	[1]
Total liabilities and stockholders’ equity	$ 340,126,000			$ 370,173,000

[1] Amounts as of December 31, 2022 and before that date differ from those published in the Company's prior consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1 - Description of Organization and Business Operations). Specifically, the number of shares of common stock outstanding during periods before the Reverse Stock Split were divided by the split ratio of 3.5:1, such that each 3.5 shares of common stock were combined and reconstituted into one share of common stock effective March 9, 2023. Fractional shares were not issued in connection with the Reverse Stock Split. Stockholders, who otherwise would have been entitled to receive fractional shares because they held a number of shares not evenly divisible by the split ratio, received an additional fraction of a share of common stock to round up to the next whole share.